AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04615819 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Peer Navigation (PN)
Description: Uses trained, previous KT recipients who meet weekly to monthly with patient participants to provide tailored information and assistance in completing the necessary steps to proceed to transplant.
Study NCT06474871 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Khymeia®-Virtual Reality rehabilitation System (VRRS EVO SYSTEM or COMPACT VRRS ENGINE)
Description: fully immersive VR software created by clinicians and experts specialized in cognitive rehabilitation. Khymeia Devices are Medical Class 1 devices according to MDR. VRRS systems consist of a central process unit, complete with a capacitive touch screen LCD monitor.
Study NCT06474871 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Traditional cognitive training (TCT)
Description: face-to-face approach between the therapist and the patient using paper and pencil tools and other traditional materials. The training of the executive abilities is carried out by working on categorization, planning, association processes, analogical reasoning, problem solving and coping strategies to simulate problematic situations, tailored on patients' deficits
Study NCT05192915 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Modular customized AFO
Description: Walks better at self selected speed with a modular customized AFO than with a conventional AFO.
Study NCT05075161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirfenidone
Description: From days 1-7: 801mg/day; from days 8-14:1602mg/day, from day 15 to ICU discharge 2403 mg/day. All drugs will be delivered by a nasogastric tube divided in 3 daily doses.
Study NCT05075161 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: All drugs will be delivered by a nasogastric tube divided in 3 daily doses.
Study NCT04947722 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PREVENT Program
Description: A standardized PREVENT educational program will be offered to each intervention LTC home and health-care staff. The curricula includes video modules with fracture-prevention care recommendations and an orientation to the Fracture Prevention Toolkit. Using the Fracture Risk Scale (i.e., a clinical decision support tool embedded in the RAI-MDS 2.0), the LTC team will identify residents at high-risk for fracture and will implement the fracture prevention recommendations into care plans on an individual resident basis.
Study NCT06403449 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group-delivered guided written exposure therapy-revised version
Description: Group-Delivered guided WET-R (G-WET) is a manualized exposure-based therapy program consisting of 5-8 sequential sessions. The interval between every 2 consecutive sessions is 0-2 days. There will be 5-8 group-delivered sessions in total (only one index trauma will be discussed), and 1-2 weeks to complete.The first and last sessions are scheduled to last for 1.5 hours each, while the other sessions will be 50 minutes in duration.
Study NCT06403449 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Waiting-List (WL) condition
Description: Participants assigned to WL will be asked to not work with other therapists or seek additional treatment for trauma-related difficulties during the 2-week WL period. After the one-month follow-up of the WET-R group, they will receive the same treatment (Group-Delivered guided written exposure therapy-revised version).WL participants will also be given contact information to use in case of worsening symptoms or increasing distress.
Study NCT05812885 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TENS
Description: Active TENS
Study NCT05812885 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: TENS
Description: Active TENS
Study NCT06563960 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: carbonated water
Description: Participants will drink carbonated water during videofluoroscopy.
Study NCT06282341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Race: Simulated marathon
Description: Participants will take part in a race: simulated marathon. Before, during, immediately after and the month after the race, neuromuscular, physiological and biomechanical assessments will take place.
Study NCT06282341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Race: Simulated trail
Description: Participants will take part in a race: simulated trail. Before, during, immediately after and the month after the race, neuromuscular, physiological and biomechanical assessments will take place.
Study NCT06282341 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Race: Trail in nature
Description: Participants will take part in a race: trail in nature. Before, during, immediately after and the month after the race, neuromuscular, physiological and biomechanical assessments will take place.
Study NCT05324241 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fat Microcapsules
Description: Consumption of a drink that contains microencapsulated fat that will be released either in the stomach or in the distal small intestines.
Study NCT05834907 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Circle of Security Parenting
Description: COS-P is an attachment-based, home visiting intervention intended to supporting parents in serving as a secure base from which their children can explore the world, and to which their children can return in times of distress (Bowlby, 1988). Such secure base parenting increases the likelihood of children's secure attachment. COS-P also targets parental responses to children's expression of their needs (e.g., crying), and is designed to help parents understand the ways in which their own (parental) dysregulated emotional, physiological, and behavioral responses to children's emotions and behaviors can limit their responsiveness to their children's attachment needs.
Study NCT05834907 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Little Talks
Description: Little Talks is an early literacy home visiting intervention developed for low-income, racial and ethnic minority infants and toddlers, and has been tested in Early Head Start contexts (Manz et al., 2016; Manz et al. 2017). Little Talks uses book sharing to promote early literacy and has been adapted in both English and Spanish. The intervention utilizes modular treatments during home visits, teaching parents how to facilitate language interactions with their children through book sharing. Age appropriate books are given to parents to share with their children during the intervention.
Study NCT04920903 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: COR588
Description: Increasing doses of COR588 will be administered for cohorts 1-4 in the single ascending dose phase and for cohorts 1-4 in the multiple ascending dose phase.
Study NCT04920903 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered for cohorts 1-4 in the single ascending dose phase and for cohorts 1-4 in the multiple ascending dose phase.
Study NCT06331520 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Netupitant / Palonosetron Oral Capsule [Akynzeo]
Description: Akynzeo is the fixed-combination antiemetic comprising netupitant (neurokinin-1 receptor antagonist \[NK1 RA\]) and palonosetron (5-hydroxytryptamine-3 receptor antagonist \[5-HT3 RA\]).
Study NCT05218044 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cryoablation
Description: The cryoprobe tip will be inserted into the breast and directed under ultrasound guidance to the location where the ultrasound visible marker is located. Next, the cryoprobe will be used to freeze a 4 X 3 X 3 cm diameter area of DCIS using two separate 10-minute freeze cycles separated by a single 10-minute thaw cycle. The cryoprobe will remain in place the entire time. After the second freeze, the cryoprobe will be withdrawn from the breast and a bandage will be applied to the skin.
Study NCT06331520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Netupitant / Palonosetron Oral Capsule [Akynzeo]
Description: Akynzeo is the fixed-combination antiemetic comprising netupitant (neurokinin-1 receptor antagonist \[NK1 RA\]) and palonosetron (5-hydroxytryptamine-3 receptor antagonist \[5-HT3 RA\]).
Study NCT06331520 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Olanzapine
Description: Olanzapine is an effective antipsychotic drug used in psychiatry to treat psychoses, especially schizophrenia and schizoaffective disorders. It belongs to the 2nd generation antipsychotics, its mechanism of action ranks among multireceptor antagonists (MARTA); it affects the dopamine, serotonin, adrenaline, histamine, and muscarinic systems.
Study NCT06331520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Olanzapine
Description: Olanzapine is an effective antipsychotic drug used in psychiatry to treat psychoses, especially schizophrenia and schizoaffective disorders. It belongs to the 2nd generation antipsychotics, its mechanism of action ranks among multireceptor antagonists (MARTA); it affects the dopamine, serotonin, adrenaline, histamine, and muscarinic systems.
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration
Description: Undergo bone marrow aspiration
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Biopsy
Description: Undergo bone marrow biopsy
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dual-Energy Computed Tomography
Description: Undergo DECT/MRI scan
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo echocardiography
Study NCT06195891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Given IV
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo DECT/MRI scan
Study NCT06195891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given IV
Study NCT06195891 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multigated Acquisition Scan
Description: Undergo MUGA scan
Study NCT06195891 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Partially Engineered T-regulatory Cell Donor Graft TRGFT-201
Description: Given IV
Study NCT06195891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tacrolimus
Description: Given tacrolimus
Study NCT06195891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thiotepa
Description: Given IV
Study NCT06195891 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Total Marrow and Lymphoid Irradiation
Description: Undergo TMLI
Study NCT06331520 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone Oral
Description: synthetic glucocorticoids
Study NCT05061030 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: the ATMP Protrans
Description: Protrans consists of Wharton's jelly derived mesenchymal stromal cells
Study NCT05061030 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: the ATMP Protrans
Description: Protrans consists of Wharton's jelly derived mesenchymal stromal cells
Study NCT06264167 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: High-resolution bilateral groin ultrasound surveillance
Description: Participants in the Interventional Treatment (serial ultrasounds) group will undergo surgical excision of the primary tumor, either via radical wide local excision or radical vulvectomy. Post-vulvar surgery, follow-up appointments occur bi-monthly for 12 months, involving a clinical examination and groin ultrasound. Senior imaging specialists review bilateral ultrasound scans for positive lymph nodes or suspicious findings, promptly sending reports to the primary care physician and trial manager if detected within 3 business days. Subsequently, participants consult their primary care physician for options. Depending on clinical judgment, they may be referred for LND or continue with bi-monthly ultrasounds based on preference and clinician guidance.
Study NCT05068193 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: BR2008-1 (R)
Description: After fasting at least 10 hours, two tablets of BR2008-1 will be administered orally with 150mL of water around 8 a.m.
Study NCT05506254 — intervention group
Intervention type: DRUG
Intervention: hLB-001
Description: hLB-001 gene therapy
Study NCT06173466 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Description: Liposomal bupivacaine 133mg was injected to paravertebral intervals of right T7/8, T8/9, T9//10, T10/11 via ultrasound-guided TPVB
Study NCT06173466 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride combined with dexamethasone
Description: Standard bupivacaine combined with dexamethasone 4mg was injected to paravertebral intervals of right T7/8, T8/9, T9//10, T10/11 via ultrasound-guided TPVB
Study NCT05904028 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
Description: Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
Study NCT05904028 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
Description: Intravitreal injections of 6 mg faricimab on a Home OCT-guided treatment schedule
Study NCT05348096 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low-dose ibrutinib
Description: Daily ibrutinib (140mg QD) and itraconazole (100mg BID) for six months.
Study NCT06019299 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness Practice
Description: Participants were instructed to practice mindfulness daily using their instructed approaches for a period of 4 weeks.
Study NCT05465304 — intervention group
Intervention type: DRUG
Intervention: Azithromycin
Description: The assessment of efficacy of azithromycin in preventing premature labour.The duration between administrating azithromycin as monotherapy and polytherapy and labour is calculated
Study NCT05703685 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: Lung scan
Description: Immediately after the brain scan
Study NCT05703685 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Apremilast
Description: Oral administration of apremilast
Study NCT06019299 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mindfulness Practice
Description: Participants were instructed to practice mindfulness daily using their instructed approaches for a period of 4 weeks.
Study NCT06105333 — intervention group
Intervention type: PROCEDURE
Intervention: standard care plus cerebral oxygen saturation monitoring with a dedicated treatment guideline
Description: CrSO2 (Cerebral regional oxygen saturation) monitoring was visible to the clinical team with the same SpO2 target as in the control group. If SpO2 (oxygen saturation) remained between the 10th and 90th centiles and within local limits, and crSO2 was \<10th centile according to published reference ranges, FiO2 (fraction of inspired oxygen) was increased by 10-20% every 60 seconds or respiratory support was started or increased. If crSO2 remained >10th centile for >60 seconds or if rSO2 was >90th centile,FiO2 was reduced by 10-20% or respiratory support was adjusted accordingly. If there was a history of blood loss or clinical signs of blood loss, intravenous fluids (10 mL/kg) were considered.
Study NCT04435236 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cervical ESP block
Description: Cervical ESP block will be performed as described by Elsharkawy at al. (7). ISB block will be performed in transverse orientation of the ultrasound probe to visualize the trunks of the brachial plexus between the anterior and middle scalene muscles
Study NCT04435236 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Cervical ESP block
Description: Cervical ESP block will be performed as described by Elsharkawy at al. (7). ISB block will be performed in transverse orientation of the ultrasound probe to visualize the trunks of the brachial plexus between the anterior and middle scalene muscles
Study NCT04971447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gender affirming hormonal treatment in transgender men
Description: testosterone enanthate
Study NCT04971447 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gender affirming hormonal treatment in transgender women
Description: GnRH agonists + estrogen
Study NCT06081049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: 0.5 mg once daily
Study NCT06081049 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Once daily
Study NCT05068193 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: BR2008 (T)
Description: After fasting at least 10 hours, one tablet of BR2008 will be administered orally with 150mL of water around 8 a.m.
Study NCT04888234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ru-Yi-Jin-Huang Powder
Description: Ru-Yi-Jin-Huang Powder is the most common TCM topical drug for skin diseases. It is often used to treat skin ulcers, sprain of joint with swelling, and other inflammatory diseases.
Study NCT05759117 — intervention group
Intervention type: PROCEDURE
Intervention: thoracentesis
Description: A type of pleural procedure that will yield pleural fluid for subsequent analysis
Study NCT05128370 — intervention group
Intervention type: OTHER
Intervention: Visual observation of arm swing during walking
Description: The gait pattern of the stroke patients will be scored based on a visual observation scale. Additional components concerning the arm swing have been added to an existing scale.
Study NCT05790421 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Foot Muscle Energy Technique
Description: Starting from the preparation position, at the restriction barrier, the patient is asked to exert a small effort (no more than 20% of available strength) towards plantarflexion, against unyielding resistance, with appropriate breathing. The patient produces isometric effort contracts either gastrocnemius or soleus (depending on whether the knee is unflexed or flexed). This contraction is held for 7-10 seconds together with a held breath. The exercise was repeated until the full range of movement was obtained.
Study NCT05790421 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physical Therapy Program
Description: Graduated active resisted range of motion exercises for both UL and LL and graduated gait training
Study NCT04704141 — intervention group
Intervention type: DRUG
Intervention: Hormone replacement therapy
Description: A hormone replacement regimen using any medication of a number of standard treatment options
Study NCT05306171 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online training for healthcare professionals
Description: The online training (4 modules) will use the technique of hybrid learning, combining meetings that will require the presence of participants and mediator at the same time and platform (live) with recorded meetings (interviews with experts) that will be watched by the participants at any time (from a distance).~Module 1: Self Care; Module 2: Stress and anxiety management; Module 3: Relationships; Module 4: Communication.
Study NCT05514236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality Therapy
Description: Participants will be given the virtual reality device (a headset) with immersive video content for use during the hysteroscopy. Designated moving objects with sound will be broadcasted on the screen to the participant in this group.~Participant can adjust the volume of the sound according to her comfort.
Study NCT05514236 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Participants will be given a headphone playing either classical light music or 'POP' songs according to their option during the hysteroscopy.~Participant can adjust the volume of the music according to her comfort.
Study NCT05380323 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3541105
Description: Administered SC.
Study NCT05380323 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC.
Study NCT06138119 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: stereotype threat manipulation
Description: Stereotype threat is the thought that a person will be negatively evaluated and judged regarding a negative stereotype that belongs to the group to which he/ she belongs. Stereotype threat manipulation will be performed on the male and female participants in the experimental group just before they are taken into the testing room. For manipulation, the following sentences will be said to the participants in the experimental group: We aim to compare fiberoptic intubation performance between male and female anesthesiologists. Additionally, we are investigating whether the high inclination of males towards computer games has any impact on their fiberoptic intubation success. The other participants (Control Group) will not be given any prior information.
Study NCT05811026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Periorbital rejuvenation with a 1927 nm diode laser treatment (2-week interval)
Description: * Visit 1 (W0): Clear + Brilliant™ Permea device periorbital treatment~* Visit 2 (W2): Clear + Brilliant™ Permea device periorbital treatment~* Visit 3 (W4): Clear + Brilliant™ Permea device periorbital treatment~* Visit 4 (W8): Four weeks after the third treatment, a follow-up assessment will be performed